More on Orasure Q1 results

Orasure Technologies (OSUR -0.8%) net revenues: $23.5M (+10.8%); Oraquick: $10.7M (+3%); gross profit: $13.9M (+15.8%); operating loss: ($5.6M) (+47.2%); net loss: ($5.6M) (+45.1%); cash burn: ($7.7M) (unch).

Revenue by market: infectious disease testing: $11.1M (+4%); substance abuse testing: $1.8M (-19%); cryosurgical systems: $4M (+29%); molecular collection systems: $5.8M (+46%); insurance risk assessment: $$917K (-9%).

Oraquick revenue: domestic: $9.2M (-3.2%); international: $1.5M (+83.1%).

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs